Search global stocks & ETFs...Ctrl K
Learn Mode
GDRX logo

GDRX - GoodRx Holdings Inc

23


$2.49

-$0.12 (-4.598%)
At market close

$2.47

-$0.02 (-0.683%)
Pre Market 5/15/26, 11:36 AM
Stock Unlock LogoScore

3.29/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
GDRX
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$1.85$5.17MayJulSepNovJanMar

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $843.30M
  • Industry
    Health Care
  • EPS (TTM)
    $0.06
  • P/E (TTM)
    41.02
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    1.07
  • P/B
    1.36
  • Diluted Shares
    341.42M
  • Ex-Dividend
    --
  • Next Earnings
    08-04
  • Forward P/E
    7.47
  • Payout Ratio
    --
  • P/FCF (TTM)
    8.74
  • FCF Yield
    11.45%
  • Earnings Yield
    2.44%
  • 52 Week Range
3.29
Average
GoodRx Holdings Inc has seen its revenue decline by -1.19% over the past year, which means the company is losing sales/customers. However, it has seen its diluted average shares outstanding decrease by -10.07% over the past year, which suggests the company is buying back shares.
Valuation Model
Key Score
1.00
Very Bad
Management
5.00
Very Good

Growth
4.00
Good

Profitability
2.00
Bad
Fin. Health
4.00
Good

Dividends
--
--

Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab
Buy
Sell
2020202120222023202420252026$0$95M$190M$285M$380M
Market News
Page 1 of 21
Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-13 17:00:10


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-12 18:49:20


Form 10-Q
General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-06 16:15:07


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-06 16:13:29


Form 3
Initial statement of beneficial ownership of securities - general instructions

Filed on 2026-05-01 17:29:09


Form ARS
Unknown Form Type

Filed on 2026-04-29 16:17:32


Form DEFA14A
Additional definitive proxy soliciting materials

Filed on 2026-04-29 16:15:03


Form DEF 14A
Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-29 16:14:25


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-24 16:29:26


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-15 17:54:41


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-15 17:54:22


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-03 16:09:21

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2022202320242025-$300M$0$300M$600M$900M
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-04-25
High:
$3.68
47.6%
Avg:
$2.87
15.3%
Low:
$1.92
-22.9%
(% change is relative to the current stock price: $2.49)
Analyst Recommendations
Go to Analyst Tab
3.57
Good
19%
Strong Buy (4)
29%
Buy (6)
43%
Hold (9)
10%
Sell (2)
0%
Strong Sell (0)
About
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 697 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
  • IPO Date
    2020-09-23
  • Industry
    Health Care
  • Total Employees
    697
  • Exchange
    Nasdaq Nms - Global Market
  • Reporting Currency
    USD
  • GICS
    Health Care Technology
  • GICS Sub
    Health Care Technology
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services